Dr. Chapa’s Clinical Pearls. 2024 CDC MEC UPDATE! HOT OFF THE PRESS!
Aug 8, 2024
The latest updates to the CDC's birth control guidelines are finally here! Discover the implications for hormonal methods and the safety of contraceptives in specific populations. Key discussions include changes regarding migraines with aura and IUD placements in postpartum scenarios. The expert insights shed light on how these recommendations will impact patient counseling and health advocacy efforts. Stay informed on the evolving landscape of contraceptive recommendations!
AI Snips
Chapters
Transcript
Episode notes
Migraines With Aura and Birth Control Risk Unchanged
- Migraines with aura and combination birth control are still a Category 4 risk, unchanged from 2016.
- This is due to a potential increased risk of stroke, despite newer birth control formulations.
Misoprostol and IUD Placement
- The CDC now advises against routine misoprostol use for IUD placement.
- Consider it for specific situations like failed placements, but explore ultrasound guidance as an alternative.
New Estrogens Grouped as CHC
- Newer estrogens like estradiol valerate and estetrol are grouped with ethinyl estradiol as CHC.
- The CDC acknowledges limited safety data on these newer estrogens with specific medical conditions.